| Dr Matthew Preston Hughes, MD | |
|
835 Cogburn Ave Nw, Suite 250, Marietta, GA 30060-1001 | |
| (770) 422-8815 | |
| (770) 422-8816 |
| Full Name | Dr Matthew Preston Hughes |
|---|---|
| Gender | Male |
| Speciality | Micrographic Dermatologic Surgery (mds) |
| Experience | 9 Years |
| Location | 835 Cogburn Ave Nw, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215220454 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Skin Cancer Specialists P C | 6800885757 | 26 |
News Archive
A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney intact.
The number of U.S. patients infected with a rare but dangerous fungal "superbug" called Candida auris has climbed quickly to 200 as of Dec. 31, according to the latest figures from the federal Centers for Disease Control and Prevention.
The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.
The same bee and other insect venom shots that doctors use to prevent deadly systemic reactions to insect stings can also tone down large local allergic reactions that, while not dangerous, can be painful and inconvenient, a Johns Hopkins study shows. Results of the study are published in the June 2009 Journal of Allergy and Clinical Immunology.
Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.
› Verified 4 days ago
| Entity Name | Skin Cancer Specialists P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114022167 PECOS PAC ID: 6800885757 Enrollment ID: O20040507000201 |
News Archive
A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney intact.
The number of U.S. patients infected with a rare but dangerous fungal "superbug" called Candida auris has climbed quickly to 200 as of Dec. 31, according to the latest figures from the federal Centers for Disease Control and Prevention.
The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.
The same bee and other insect venom shots that doctors use to prevent deadly systemic reactions to insect stings can also tone down large local allergic reactions that, while not dangerous, can be painful and inconvenient, a Johns Hopkins study shows. Results of the study are published in the June 2009 Journal of Allergy and Clinical Immunology.
Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Preston Hughes, MD 835 Cogburn Ave Nw, Suite 250, Marietta, GA 30060-1001 Ph: (770) 422-8815 | Dr Matthew Preston Hughes, MD 835 Cogburn Ave Nw, Suite 250, Marietta, GA 30060-1001 Ph: (770) 422-8815 |
News Archive
A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney intact.
The number of U.S. patients infected with a rare but dangerous fungal "superbug" called Candida auris has climbed quickly to 200 as of Dec. 31, according to the latest figures from the federal Centers for Disease Control and Prevention.
The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.
The same bee and other insect venom shots that doctors use to prevent deadly systemic reactions to insect stings can also tone down large local allergic reactions that, while not dangerous, can be painful and inconvenient, a Johns Hopkins study shows. Results of the study are published in the June 2009 Journal of Allergy and Clinical Immunology.
Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.
› Verified 4 days ago
Jordan Thompson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 835 Cogburn Avenue, Suite 100, Marietta, GA 30060 Phone: 770-422-5557 Fax: 770-422-5456 | |
Ms. Onaopemipo Olayide Ofodile, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4800 Olde Towne Pkwy Ste 250, Marietta, GA 30068 Phone: 770-971-3376 | |
Jennifer L Jones, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 835 Cogburn Avenue, Suite 100, Marietta, GA 30060 Phone: 770-422-5557 Fax: 770-422-5458 | |
Clem Melton Doxey Jr., M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 111 Marble Mill Rd Nw, Marietta, GA 30060 Phone: 770-422-1013 Fax: 770-514-5996 | |
Dr. Alan M Gardner, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2550 Windy Hill Rd Se, Suite 220, Marietta, GA 30067 Phone: 770-952-2100 Fax: 770-850-9712 | |
Dr. Jennifer Louise Buckley, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 835 Cogburn Ave Nw, Suite 100, Marietta, GA 30060 Phone: 770-422-5557 Fax: 770-422-5456 |